To analyze if AR chromatin-binding profile is shared between prostate cancer cell models and clinical PCa samples, we compared VCaP ARB data with those from LNCaP, LNCaP/C4-2B and 22RV1 cells and from patient samples11, 15, 17, 18. This evidence concerns the gene AR and prostate cancer.